GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001
etanercept is an approved drug (FDA (1998), EMA (2000))
Compound class:
Peptide
Comment: Etanercept is a TNFα inhibitor. It is a dimeric recombinant protein fusing the TNF receptor 2 (TNFRSF1B) to the Fc region of the human IgG1 antibody. Etanercept is used as a disease-modifying anti-rheumatic drug (DMARD).
Biosimilars:
View more information in the IUPHAR Pharmacology Education Project: etanercept |
Classification ![]() |
|
| Compound class | Peptide |
| Approved drug? | Yes. US FDA (1998) | EU EMA (2000) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7783 | etanercept |
Synonyms ![]() |
| Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 216 |
| Other databases | |
| CAS Registry No. | 185243-69-0 |
| ChEMBL Ligand | CHEMBL1201572 |
| DrugBank Ligand | DB00005 |
| GtoPdb PubChem SID | 178103395 |
| PubChem SID | 135343504 |
| Search PubMed clinical trials | etanercept |
| Search PubMed titles | etanercept |
| Search PubMed titles/abstracts | etanercept |
| Wikipedia | Etanercept |